Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Advances in Experimental Medicine and Biology
|
July 17, 2024
The Role of the Transcriptional Coactivator BOB.1/OBF.1 in Adaptive Immunity
Annika C Betzler, Cornelia Brunner
Frontiers in Immunology
|
February 23, 2023
The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells
Annika C Betzler, Alexey Ushmorov, Cornelia Brunner
Frontiers in Immunology
|
October 23, 2023
Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
Jiantong Bao, Annika C Betzler, Jochen Hess, et al.
Frontiers in Immunology
|
December 6, 2023
Corrigendum: Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
Jiantong Bao, Annika C Betzler, Jochen Hess, et al.
European Journal of Immunology
|
March 18, 2021
Impaired Peyer's patch development in BOB.1/OBF.1-deficient mice
Annika C Betzler, Katja Fiedler, Enikö Kokai, et al.
European Journal of Immunology
|
December 17, 2021
BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function
Annika C Betzler, Katja Fiedler, Thomas K Hoffmann, et al.
Frontiers in Immunology
|
May 23, 2022
T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell Differentiation
Annika C Betzler, Jasmin Ezić, Tsima Abou Kors, et al.
International Journal of Molecular Sciences
|
June 4, 2020
NF-κB and Its Role in Checkpoint Control
Annika C Betzler, Marie-Nicole Theodoraki, Patrick J Schuler, et al.
Frontiers in Cell and Developmental Biology
|
March 14, 2022
Differential Requirement of Vav Proteins for Btk-dependent and -Independent Signaling During B Cell Development
Annika C Betzler, Sebastian Kieser, Katja Fiedler, et al.
Neoplasia (New York, N.Y.)
|
November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells
Adrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Advances in Experimental Medicine and Biology
|
July 17, 2024
The Role of the Transcriptional Coactivator BOB.1/OBF.1 in Adaptive Immunity
Annika C Betzler, Cornelia Brunner
Frontiers in Immunology
|
February 23, 2023
The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells
Annika C Betzler, Alexey Ushmorov, Cornelia Brunner
Frontiers in Immunology
|
October 23, 2023
Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
Jiantong Bao, Annika C Betzler, Jochen Hess, et al.
Frontiers in Immunology
|
December 6, 2023
Corrigendum: Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
Jiantong Bao, Annika C Betzler, Jochen Hess, et al.
European Journal of Immunology
|
March 18, 2021
Impaired Peyer's patch development in BOB.1/OBF.1-deficient mice
Annika C Betzler, Katja Fiedler, Enikö Kokai, et al.
European Journal of Immunology
|
December 17, 2021
BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function
Annika C Betzler, Katja Fiedler, Thomas K Hoffmann, et al.
Frontiers in Immunology
|
May 23, 2022
T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell Differentiation
Annika C Betzler, Jasmin Ezić, Tsima Abou Kors, et al.
International Journal of Molecular Sciences
|
June 4, 2020
NF-κB and Its Role in Checkpoint Control
Annika C Betzler, Marie-Nicole Theodoraki, Patrick J Schuler, et al.
Frontiers in Cell and Developmental Biology
|
March 14, 2022
Differential Requirement of Vav Proteins for Btk-dependent and -Independent Signaling During B Cell Development
Annika C Betzler, Sebastian Kieser, Katja Fiedler, et al.
Neoplasia (New York, N.Y.)
|
November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells
Adrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
Page
of 2